Andy Jassy's advice for founders and AI investment frameworks: January updates from Bessemer
Bessemer Venture Partners
For the entrepreneurs who want to build revolutions of their own.
Discover why startup leaders need "blind faith—but no false hope" and how AI-designed medications are set to transform healthcare.
Welcome to Bessemer's inaugural LinkedIn newsletter. Subscribe for biweekly updates from the partnership, including firm news and industry-leading insights on building and investing in startups.
Startup wisdom from Amazon CEO Andy Jassy
"You need blind faith—but no false hope."
At our 2024 Cloud 100 Celebration in San Francisco, Andy Jassy , President and CEO of Amazon, shared invaluable advice for startups navigating today's competitive landscape.
You must have blind faith—believe in your vision and invest fully—but it must be grounded in reality. Regularly validate your idea with customers to ensure it resonates. Without this alignment, you risk building something irrelevant.
Get deeper insights, like Andy's full lesson, on our full email newsletter.
In case you missed it
Read our Vertical AI investment framework: In our final installment of the Vertical AI roadmap, we share essential advice for founders on how to drive early-stage value and defensibility. Read more.
Bessemer Venture Partners leads ShopMy's $77.5 million Series B fundraise: ShopMy solves key brand partnership challenges in the creator economy. Read our Founder Q&A:
Bessemer Venture Partners leads HockeyStack's $20 million Series A fundraise: HockeyStack enables marketers to consolidate, analyze, and act on their data, without needing data science expertise. Read more.
Bessemer Venture Partners leads Inrisk's Seed fundraise. Inrisk Labs builds parametric insurance products for India's agriculture sector. Read more.
Janelle Teng promoted to Partner: Based in Bessemer's Silicon Valley offices, Janelle Teng invests in early-stage AI/ML infrastructure, defense tech, data infrastructure, and developer platforms. "I'm profoundly honored to share this journey with all the incredible founders I’ve had the privilege of working with," she shares.?Learn more about Janelle:
Lauri Moore talks AI startup revenue with The Information: One of our partners, Lauri J. Moore , shares her perspective on the impact of AI on software startups' annual recurring revenue (ARR) scaling journey.?Read more.?
AI-designed medications: The next frontier in healthcare
The healthcare industry is on the cusp of a revolutionary breakthrough: AI-designed medications are poised to enter clinical trials, marking a significant shift in how we approach drug discovery and development.
Traditional methods of drug development are time-consuming and costly. However, with AI algorithms capable of designing medications without a starting point, we're entering an era where AI-native biotechs could create blockbuster therapeutics faster and more efficiently than ever before.
What does this mean for the biotech industry?
Want more Bessemer updates? Be the first to get our full ICYMI on our email newsletter. Subscribe today.
Join the conversation! What are your thoughts on Andy Jassy's advice for startups or AI's impact on vertical software and biotech? Comment below and share your POV.
Anesthesiologist @ Department of Health South Africa | Critical Care Medicine, Healthcare
1 个月AI designed Medication from Drug discovery is a game changer in the fight against superbugs!. Through accelerated research and development of new drugs, more lives can be saved at a fraction of time and cost. Commendable exciting innovations. Thank you for sharing.
Global Head of Content @ Bessemer Venture Partners | Marketing Leader
1 个月Love to see this — great source to stay up to date on venture insights that matter!